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Included in the recent search for more effective insecticides has been the quest
for a more satisfactory remedy for scabies. A number of new anti-scabitic
drugs have appeared as a result of this work, some of which are a distinct im-
provement over the older sarcopticides. An ideal scabicide, as defined by a
number of authors (1), should possess the following characteristics:
1. It must rapidly and effectively kill the parasite (adult and ova), making the
course of treatment short.
2. It must be harmless to the patient (nonirritating, nontoxic).
3. It must be practically odorless, and non-messy.
4. It must not stain or damage clothing.
5. It must not aggravate a pyoderma when present, but rather, diminish it.
6. It must not aggravate existing pruritus, but, if possible, afford rapid
relief.
7. It must be easily applied, preferably without preceding bath, and it should
not interfere with the patient's occupation.
8. It must be readily available, at a reasonable price.
Most of our scabicides, if not all, have fallen short of one or more of these re-
quirements, as has been pointed out repeatedly (2). Among the objections
raised against them are production of contact dermatitis, toxic manifestations,
burning on application, objectionable odor or color, staining of clothing, difficulty
of therapeutic procedure, aggravation of existing pyoderma, and a high percent-
age of relapses.
Recently Domenjoz (3) reported on the parasiticidal action of a new synthetic
compound, N-ethyl-o-crotono-toluidide. The antiparasitic action of this chemi-
cal was discovered during a systematic investigation of more than 1100 newly
synthesized compounds which were initially tested on Psoroptes cuniculi, the
cause of scabies in rabbits. Besides the above mentioned compound, other
effective sarcopticides were found in the course of this investigation. Two com-
pounds which were clinically quite successful were later rejected for human use
because of some undesirable side reactions (3, 4).
The compound N-ethyl-o-crotono-toluidide, as reported by Domenjoz, has
been given the following structural formula:
CH3
0H3—CH=CH—C O—N—
CH2
C113
* From the Department of Dermatology and Syphilology, School of Medicine, College
of Medical Evangelists, Los Angeles, Calif.
Received for publication March 1, 1949.
35
36 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
In its pure form this is a colorless, odorless oily liquid with a specific gravity
of 1.009, and a pH of 6. It is practically insoluble in water but dissolves in oils
and fats, alcohol, acetone, and ether. In the original investigations of Domenjoz
and his associates, N-ethyl-o-crotono-toluidide proved to be relatively nontoxic
and nonirritating to rabbits, guinea pigs, rats, and mice, with similar results
later in man. The lethal dose for mice was found to be 1600 mg/kg., and for
rats 1500 mg/kg.
The scabicidal action of N-ethyl-o-crotono-toluidide was demonstrated by its
lethal action in concentrations of 5 and 10 per cent on Psoroptes cuniculi within
10 minutes after exposure, while a 2 per cent concentration killed this organism
in 10 to 30 minutes. Comparative studies with other scabicides, including
benzyl benzoate, showed N-ethyl-o-crotono-toluidide to be superior to these in
its lethal action on Psoroptes cuniculi. Studies on the bacteriostatic effect of
this substance on staphylococci and streptococci shows it to be definitely in-
hibitory to the growth of these microorganisms, but not to E. coli.
Burckhardt and Rymarowicz (5) in 1946 reported on the first clinical investi-
gations with N-ethyl-o-crotono-toluidide in the treatment of human scabies.
They treated 326 ambulatory patients, of which 252 were re-examined after
completion of treatment. Most of these patients were treated with a washable
ointment containing 10 per cent of the active substance, while a smaller number
used ointments containing 5 and 8 per cent. In most cases two applications of
the ointment were made on two successive nights, with or without bathing. Of
the 252 patients which were re-examined 3 to 6 weeks after their treatment, 7
patients were found to be infected with scabies, while 6 other patients still showed
some isolated papules, but without burrows, which were classified as probably
still infected. It was impossible to determine if these represented reinfections
or relapses, but all were cured after a second course of treatment. These authors
recommended that in severely crusted and secondarily infected patients the
treatment be continued for an additional two days. The bacteriostatic proper-
ties of N-ethyl-o-crotono-toluidide were noted in the clearing of the secondary
pyoderma present in many of the above cases of scabies, as well as in the treat-
ment of impetigo as such. If the 13 cases which needed retreatment are con-
sidered as failures, the cure rate with two applications of a 10 per cent concen-
tration of N-ethyl-o-crotono-toluidide was about 95 per cent. Burckhardt and
Rymarowicz observed no cutaneous irritation or secondary systemic effects in
this series of cases.
Lenggenhager (6) in 1947 reported 350 cases of scabies treated with some of the
newer scabicides, including 100 cases treated with 10 per cent N-ethyl-o-crotono-
toluidide in a washable ointment base. He observed a cure rate of 96 per cent,
but reported in this series 33 local reactions and 7 general reactions to this drug.
The local reactions consisted of a persistent pruritus which lasted several days,
a few eczematoid reactions, especially in areas where the scabitic infestation had
been most severe, and one case of erythrodermia, which cleared after one week.
These patients were all shown to have a negative reaction to N-ethyl-o-crotono-
toluidide on patch testing. The 7 patients said to have shown general reactions
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to the ointment complained of slight headaches and nausea, which disappeared
rapidly.
It is noteworthy that in both the series of Lenggenhager and that of Burek-
hardt and Rymarowicz the effectiveness of N-ethyl-o-crotono-toluidide as a
scabicide was practically identical. Lenggenhager, however, reported mild local
and general reactions, which were not noted by the previous investigators. It
may be said that the evaluation of pruritus as a local reaction to treatment in a
scabitic patient, already suffering from the itching incident to his infection, is a
somewhat difficult problem. Burckhardt and Rymarowicz noted in their paper
that in most cases of scabies the sensation of itching disappeared while the
medication was still being applied, and this observation has been verified by a
number of workers since that time. The investigation of this antipruritic
action of N-ethyl-o-crotono-toluidide was made a part of the work reported on
in this paper.
PRELIMINARY INVESTIGATIONS
In the studies recorded below, N-ethyl-o-crotono-toluidide was used in a 10
per cent concentration in a washable ointment base,' except where it is specifically
stated that a different concentration or base was used.
The reports which were available when these investigations were started in
April, 1947, indicated that N-ethyl-o-crotono-toluidide was a drug of very low
toxicity for man. The first part of my investigation was an appraisal of existing
sensitivity to the drug, and the manifestation of systemic reactions from its
cutaneous application. After twenty subjects failed to show a positive reaction
to the drug with a standard 48-hours patch test, the 10 per cent ointment was
applied to the entire body for two succeeding nights, and the same procedure
repeated two weeks later. No local reaction was observed, except a transient
feeling of warmth on the inner thighs and eyelids, and no evidence of systemic
reaction. Blood counts and urinalyses also failed to show any changes. Patch
testing was then continued, and at the same time such patients with scabies as
were available were treated with the 10 per cent ointment, as described below,
and observed as to their reaction to the drug and the effect on the infection. A
total of 100 individuals were patch tested to the 10 per cent concentration of
N-ethyl-o-crotono-toluidide, and all of these gave a negative result except four
who showed a mild erythema without edema or vesiculation (Table 1). These
four were re-tested with a 10 per cent concentration of N-ethyl-o-crotono-
toluidide in petrolatum, and they failed to show any reaction whatsoever to
this ointment. Two of them were also patch tested to the pure drug without
any reaction. Evidently the mild sensitivity was not to the active substance but
to the washable ointment base. An additional forty individuals have been patch
tested to this petrolatum ointment containing 10 per cent of the active substance,
and thirty were patch tested to the pure N-ethyl-o-crotono-toluidide. No
sensitivity reaction or evidence of primary irritation was observed in any of
'This preparation was supplied by the Geigy Company, 89—91 Barclay Street, New York,
N. Y., and is marketed in Europe under the name Eurax.
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these tests. Thirty individuals were re-tested one year after having shown a
negative reaction to their original patch test, and none of these showed a sensi-
tivity reaction on re-testing. No development of sensitivity was noted among
the nearly two hundred patients who used the 10 per cent ointment, except in
three cases, as described below, and in these the reaction was mild and the sensi-
tivity was due to the washable ointment base, as shown by patch testing and
clinical trial with the 10 per cent petrolatum ointment.
In the course of the investigation on the scabicidal action of N-ethyl-o-crotono-
toluidide it was noticed that many of the patients who were treated remarked
about the immediate cessation of their itching when the ointment was applied.
This same effect had been noted incidentally by Burckhardt and Rymarowicz
(5). Since it seemed important to pursue this line of investigation also, a second
series of patients who complained of pruritus of non-scabitic origin was studied
TABLE 1
Results of the 48 hour patch ie.t to N-ethyl-o-crotono-toluidide
CONCENTRATION AND VENICLE
TOTAL
NtThSBER
OP CASES
REACTIONS
Negative Erythemaonly
Erythema
with Edema Vesiculation Necrosis
10% in a washable ointment
base
10% in petrolatum
Pure N-ethyl-o-crotono-tolui-
dide
100
40
30
96
40
30
4*
0
0
0
0
0
0
0
0
0
0
0
Totals 170 166 4* 0 0 0
* The four individuals giving a mild erythema reaction proved to be sensitive to the
washable ointment base, and gave a negative reaction to a 10% concentration of N-ethyl-
o-crotono-toluidide in petrolatum.
in order to note the effect of this drug on pruritus. The results of this investi-
gation are reported below. In relation to the problem of sensitization and
systemic toxicity, it may be said here that although some of the patients in this
series have been using the 10 per cent washable ointment many months, no local
or systemic reactions have been noted. The only unusual sensation noted by
these patients was that of a transitory feeling of warmth upon application of the
ointment to certain areas of the body, especially the inner thighs, scrotum, vulva,
and eyelids. This sensation of warmth appeared a few seconds after application,
and lasted for several minutes. None of the patients felt that this sensation
was particularly objectionable.
INVESTIGATION OF SCABICIDAL ACTION
Seventy patients who were suffering from scabies were treated with a 10 per
cent concentration of N-ethyl-o-crotono-toluidide in a washable ointment base.
In 58 of these 70 patients the diagnosis of scabies was substantiated by the finding
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of Acarus scabici, while in the remaining 12 the diagnosis was made solely on the
basis of clinical findings. All patients were asked to apply the ointment to the
entire body, except the head, on two successive nights; they were told that
bathing was optional, but were advised not to scrub. It was suggested that on
the third night, after completion of treatment, the patient take an ordinary soap
and water bath. All patients were examined at weekly intervals until all evi-
dence of the eruption had disappeared. Three patients still showed large pruritic
papules one week after completion of treatment. In all three of these cases
repeated attempts were made to recover Acarus scabiei from the pruritic papules,
but this failed in two of the three individuals, while in one patient who had a
peculiar papulo-urticarial eruption, a disintegrated female Acarus was found in
one of these lesions. All three patients were asked to repeat the previous treat-
ment, and, in addition, the patient showing the papulo-urticarial eruption was
asked to apply pure N-ethyl-o-crotono-toluidide nightly to the remaining lesions.
TABLE 2
Effect of N-ethyl-o-crotono-toluidide on Scabies
CASES IN CASES DIAG- CASES CURED CASES CURED
TOTAL NUM- WHICH ACARUS NOSED ON CLIN- WITH TWO Al'- WITH MORE °R PERCENTAGE NUMBER OP
HER OF CASES SCABIRI WERE ICAL GROUNDS PLICATIONS THAN TWO AP- CURED RELAPSES
FOUND ONLY ONLY PLICATIONS CURE
70 58 12 67 3 70 100% 0
After this, all evidence of the infection disappeared. Perhaps if more patience
had been exercised, these three individuals might have manifested a cure with
the standard two applications of the 10 per cent ointment. However, all patients
suffering from scabies which were treated with N-ethyl-o-crotono-toluidide were
cured (Table 2). No evidence of contact dermatitis was noted in any of these
patients.
Four patients, 3 children and 1 adult, all members of one family, were re-
infected with scabies by a visiting cousin six months after they had been cured
from their first attack with two applications of the 10 per cent washable ointment;
the eruption disappeared promptly again with the same treatment, and none of
them showed any local or systemic reaction to this second course of treatment
six months after the first course.
In nine patients in this series who had a marked secondary pyoderma asso-
ciated with their scabitic infection the 10 per cent ointment of N-ethyl-o-crotono-
toluidide affected the secondary infection favorably, apparently shortening the
time usually required for a cure. This number is too small, however, to make
this observation more than an impression, since many factors enter into the cure
of an individual case of secondary pyoderma.
None of the patients in this series complained of an increase in their pruritus
following the application of the ointment, but many of them volunteered the
information that their itching stopped soon after the use of the medication.
Since a special anti-pruritic action was not suspected at that time, no statistics
are given on this point in this series.
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INVESTIGATION OF ANTI-PRURITIC ACTION
One hundred twenty-four patients who had pruritus as one of their chief
complaints were treated symptomatically with 10 per cent N-ethyl-o-crotono-.
toluidide in a washable ointment base. They were advised to use the ointment
as frequently as needed for the control of the itching, and to note at what time
TABLE 3
Effect of N-ethyl-o-crotono-toluidide on pruritus
MODERATE POOR SitS-
DIAGNOSIS NUMBER (COMPLETE (coNsIDER- (SLIGHT TEMIC LOCAL RE-
OF CASES RELIEF) REup) RELIEF) TION
Neurodermatitis (Including Atopic
Dermatitis) 34 20 10 4 0 1*
Pruritis Ani, Vulvae, or Scroti 26 21 4 1 0 1*
Dermatitis Venenata 18 13 4 1 0 0
Psoriasis 7 4 3 0 0 0
Varicella 5 3 2 0 0 0
Lymphoblastoma 4 2 2 0 0 1
Dermatophytosis 4 1 2 1 0 0
Lupus erythematosus 4 1 3 0 0 0
Lichen planus 3 2 1 0 0 0
Urticaria 2 2 0 0 0 0
Neurotic excoriation 2 0 2 0 0 0
Stasis dermatitis 2 1 0 1 0 0
Seborrheic dermatitis 2 2 0 0 0 0
Dermatitis hiemalis 2 2 0 0 0 0
Creeping eruption 2 2 0 0 0 0
Erythema solare 1 1 0 0 0 0
Pompholyx 1 1 0 0 0 0
Fixed drug eruption 1 0 1 0 0 0
Pityriasis rosea 1 1 0 0 0 0
Insect bites 1 1 0 0 0 0
Jaundice (catarrhal) 1 1 0 0 0 0
Infectious eczematoid dermatitis 1 1 0 0 0 0
Totals
Percentages
124
100%
82
66.2%
34
27.4%
8
6.4%
0
0
3
2.4%
* A mild erythema developed, which was proven to be due to the washable ointment
base, and which did not recur when petrolatum was used as a base.
the pruritis disappeared and at what time it reappeared.2 In those who obtained
relief from their itching with the ointment, the relief was noted almost as soon
as the ointment was applied, and in most cases the pruritus did not manifest
2 Practically none of the patients in this series was treated with the above ointment while
their dermatoses were in an acute weeping stage. Nearly all the exceptions were in the
dermatitis venenata group, and were mostly cases due to Rhus diversiloba. As a general
rule, the acute weeping phase of a dermatosis was first treated with wet compresses before
the N-ethyl-o-crotono-toluidide ointment was used.
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itself again for 6 to 10 hours, the extremes being 15 minutes to 24 hours. In all
cases in which the ointment afforded relief it continued to do so as long as it was
used, which has been for as long as 8 months in some cases of mycosis fungoides
and pruritus vulvae. Three patients who obtained relief from their pruritus
with the ointment developed a mild erythema in the area of application; all three
showed a mild reaction to the 10 per cent washable ointment when patch tested,
but a negative test to the same strength of N-ethyl-o-crotono-toluidide in
petrolatum. These patients continued to find relief from their pruritus with the
use of the petrolatum ointment, without the development of erythema.
In the series of 124 patients here reported which were treated for relief of
pruritus, 82 (66.2 per cent) obtained complete relief, 34 (27.4 per cent) found
considerable relief, and 8 (6.4 per cent) found little or no relief with the 10 per
cent ointment of N-ethyl-o-crotono-toluidide. In this series there was no evi-
cence of any systemic reaction to the drug, and there were 3 cases (2.4 per cent)
showing a local reaction, which was a mild erythema, and proved to be due to
the washable ointment base.
DISCUSSION
The results obtained by Burckhardt and Rymarowicz, and by Lenggenhager,
in the treatment of scabies with N-ethyl-o-crotono-toluidide have been corrobo-
rated by the findings in my series of cases. Similar results have recently been
obtained by Peck (7) and by Goldman (8). The evidence seems to be conclusive
that two applications of a 10 per cent ointment of N-ethyl-o-crotono-toluidide
will cure 95 to 100 per cent of all cases of scabies. There were no local or systemic
reactions in my series of scabies cases, and only Lenggenhager has reported some
mild reactions in his series of cases. From the results in my series and from those
reported by others it seems that N-ethyl-o-crotono-toluidide is as effective as the
best scabicide that has been available until now, that it is free from many,
possibly all, of the objectionable features of other sarcopticides. The question
arises whether perhaps one application of the same ointment, or one containing
a higher concentration of the active substance, might not be effective in a large
percentage of the cases, or if an ointment of lesser strength would be equally
effective.
The anti-pruritic action of N-ethyl-o-crotono-toluidide in many pruritic derma-
toses is at least strongly suggested if not actually established by the results ob-
tained in my second series of cases. The high incidence of relief in some of the
most pruritic dermatoses seems to be unexplainable on any other basis except
that of a specific anti-pruritic effect of this drug. Peck (7) and Goldman (8)
have obtained similar results. Particularly in neurodermatitis, pruritis ani et
vulvae, and dermatitis venenata, this anti-pruritic effect was most evident. The
relief of pruritus was especially gratifying in the cases of mycosis fungoides and
generalized lichen planus, since this symptom was otherwise almost uncon-
trollable.
The results obtained in the two cases of creeping eruption (due to Ankylostoma
braziliense) suggest an investigation of the action of this drug, probably in various
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concentrations, in a large series of patients suffering from this disease, as well as
in other cutaneous parasitic infections.
It is of particular importance that further work involving the use of N-ethyl-
o-crotono-toluidide should place continued emphasis on observations regarding
the presence or absence of any local or systemic reactions. The importance of
reactions to the vehicle carrying the active drug should be fully realized.
SUMMARY
Seventy cases of scabies were treated with a 10 per cent ointment of N-ethyl-
o-crotono-toluidide with a 100 per cent cure rate. Three cases required more
than the two routine applications before all clinical evidence of the disease had
disappeared. There were no local or systemic reactions.
A second series of 124 cases was treated with the same preparation for the re-
lief of pruritus in a variety of dermatoses. The larger number of cases comprised
neurodermatitis, pruritus au et vulvae, and dermatitis venenata. Complete
relief, lasting usually 6 to 8 hours, was obtained by 66.2 per cent of cases, con-
8iderable relief by 27.4 per cent of cases, while 6.4 per cent of cases found little or
no relief.
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